scispace - formally typeset
N

Nicolas Ferry

Researcher at French Institute of Health and Medical Research

Publications -  75
Citations -  2244

Nicolas Ferry is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Transgene & Genetic enhancement. The author has an hindex of 26, co-authored 75 publications receiving 2176 citations. Previous affiliations of Nicolas Ferry include École Normale Supérieure & Pasteur Institute.

Papers
More filters
Journal ArticleDOI

Binding of yohimbine stereoisomers to α‐adrenoceptors in rat liver and human platelets

TL;DR: It is concluded that the aromatic A ring, the Nb atom, and the carboxymethyl moiety are important for the binding of yohimbine to the α‐adrenoceptor, the car boxymethyl group being important forThe α1/α2 specificity of the molecule.
Journal ArticleDOI

Mature hepatocytes actively divide and express gamma-glutamyl transpeptidase after D-galactosamine liver injury.

TL;DR: It is demonstrated that hepatocytes can divide to restore the liver mass after D-galactosamine liver injury and that gamma-glutamyl transpeptidase can be re-expressed by mature hepatocytes during the recovery process.
Journal ArticleDOI

Specific Micro RNA-Regulated TetR-KRAB Transcriptional Control of Transgene Expression in Viral Vector-Transduced Cells

TL;DR: This work has developed expression systems that use combinations of a tetR-KRAB artificial transgene-repressor, endogenous miRNA silencing machinery and tissue specific promoters that provide a robust and easily adaptable method for achieving regulated transGene expression in different tissue types.
Journal ArticleDOI

In the rat liver, Adenoviral gene transfer efficiency is comparable to AAV

TL;DR: Adenoviral and Adenovirus-associated viral vectors are used for in vivo gene therapy of inherited liver disorders, such as Crigler–Najjar syndrome type 1 and the efficiency of clinically applicable doses of both vectors in the Gunn rat was compared.
Journal ArticleDOI

Long term transgene expression by hepatocytes transduced with retroviral vectors requires induction of immune tolerance to the transgene.

TL;DR: In this article, the authors investigated whether immune response could be prevented by treatment with compounds known to induce tolerance in organ transplantation: CTLA4Ig and LF-15-0195.